An in-depth analysis of ER+ breast cancer, focusing on its prevalence, molecular biology, current treatments, and emerging ...
Researchers of a Swedish study advise physicians to consult with their patients about these risks and take extra precautions, ...
PR+ breast cancer responds well to hormone therapy, underscoring the need for molecular insight and targeted treatment ...
Medically reviewed by Marla Anderson, MD Breast cancer is a type of cancer that starts growing in the breast tissue.
Data derived from Yen T-T, et al. Comparative effects of glucagon-like peptide-1 receptor agonists combined with hormone therapy on endometrial cancer risk among women with benign uterine or ...
Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine. Anixa Biosciences, Inc. March 24, 2025.
Dr. Regina Hampton shares case studies from her own practice, illustrating how genomic insights have improved patient ...
There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
Gene expression testing helps determine chemotherapy needs for hormone receptor-positive breast cancer, optimizing treatment ...